Logo image of IPR.LS

IMPRESA SGPS SA (IPR.LS) Stock Fundamental Analysis

ELI:IPR - Euronext Lisbon - PTIPR0AM0000 - Common Stock - Currency: EUR

0.105  0 (-0.47%)

Fundamental Rating

2

IPR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 65 industry peers in the Media industry. IPR has a bad profitability rating. Also its financial health evaluation is rather negative. IPR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

IPR had negative earnings in the past year.
In the past year IPR had a positive cash flow from operations.
Of the past 5 years IPR 4 years were profitable.
In the past 5 years IPR always reported a positive cash flow from operatings.
IPR.LS Yearly Net Income VS EBIT VS OCF VS FCFIPR.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

IPR has a worse Return On Assets (-0.49%) than 65.67% of its industry peers.
The Return On Equity of IPR (-1.25%) is worse than 62.69% of its industry peers.
IPR has a Return On Invested Capital of 4.50%. This is comparable to the rest of the industry: IPR outperforms 49.25% of its industry peers.
Industry RankSector Rank
ROA -0.49%
ROE -1.25%
ROIC 4.5%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IPR.LS Yearly ROA, ROE, ROICIPR.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15

1.3 Margins

IPR has a Operating Margin (6.78%) which is in line with its industry peers.
In the last couple of years the Operating Margin of IPR has declined.
The Gross Margin of IPR (35.63%) is worse than 68.66% of its industry peers.
In the last couple of years the Gross Margin of IPR has declined.
Industry RankSector Rank
OM 6.78%
PM (TTM) N/A
GM 35.63%
OM growth 3Y-24.98%
OM growth 5Y-6.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.6%
GM growth 5Y-9.29%
IPR.LS Yearly Profit, Operating, Gross MarginsIPR.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IPR is destroying value.
There is no outstanding debt for IPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IPR.LS Yearly Shares OutstandingIPR.LS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 50M 100M 150M
IPR.LS Yearly Total Debt VS Total AssetsIPR.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

2.2 Solvency

IPR has an Altman-Z score of 0.40. This is a bad value and indicates that IPR is not financially healthy and even has some risk of bankruptcy.
IPR's Altman-Z score of 0.40 is on the low side compared to the rest of the industry. IPR is outperformed by 71.64% of its industry peers.
The Debt to FCF ratio of IPR is 8.71, which is on the high side as it means it would take IPR, 8.71 years of fcf income to pay off all of its debts.
IPR has a Debt to FCF ratio of 8.71. This is comparable to the rest of the industry: IPR outperforms 44.78% of its industry peers.
A Debt/Equity ratio of 0.40 indicates that IPR is not too dependend on debt financing.
IPR has a Debt to Equity ratio of 0.40. This is comparable to the rest of the industry: IPR outperforms 59.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 8.71
Altman-Z 0.4
ROIC/WACC0.59
WACC7.6%
IPR.LS Yearly LT Debt VS Equity VS FCFIPR.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.35 indicates that IPR may have some problems paying its short term obligations.
With a Current ratio value of 0.35, IPR is not doing good in the industry: 86.57% of the companies in the same industry are doing better.
IPR has a Quick Ratio of 0.35. This is a bad value and indicates that IPR is not financially healthy enough and could expect problems in meeting its short term obligations.
IPR has a worse Quick ratio (0.35) than 85.07% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
IPR.LS Yearly Current Assets VS Current LiabilitesIPR.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

IPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -189.74%.
IPR shows a decrease in Revenue. In the last year, the revenue decreased by -0.19%.
Measured over the past years, IPR shows a small growth in Revenue. The Revenue has been growing by 1.25% on average per year.
EPS 1Y (TTM)-189.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.83%
Revenue 1Y (TTM)-0.19%
Revenue growth 3Y0.85%
Revenue growth 5Y1.25%
Sales Q2Q%1.11%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPR.LS Yearly Revenue VS EstimatesIPR.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
IPR.LS Yearly EPS VS EstimatesIPR.LS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 0.02 0.04 0.06

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IPR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPR.LS Price Earnings VS Forward Price EarningsIPR.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, IPR is valued cheaply inside the industry as 95.52% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.03
EV/EBITDA N/A
IPR.LS Per share dataIPR.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IPR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IMPRESA SGPS SA

ELI:IPR (3/7/2025, 7:00:00 PM)

0.105

0 (-0.47%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-05 2025-03-05
Earnings (Next)07-22 2025-07-22
Inst Owners1.76%
Inst Owner ChangeN/A
Ins Owners1.51%
Ins Owner ChangeN/A
Market Cap17.64M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF 1.03
P/OCF 0.98
P/B 0.12
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.1
FCFY97.23%
OCF(TTM)0.11
OCFY101.83%
SpS1.08
BVpS0.91
TBVpS-0.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.49%
ROE -1.25%
ROCE 5.7%
ROIC 4.5%
ROICexc 4.64%
ROICexgc N/A
OM 6.78%
PM (TTM) N/A
GM 35.63%
FCFM 9.42%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-24.98%
OM growth 5Y-6.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.6%
GM growth 5Y-9.29%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 8.71
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.45%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.4
F-Score4
WACC7.6%
ROIC/WACC0.59
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-189.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.19%
Revenue growth 3Y0.85%
Revenue growth 5Y1.25%
Sales Q2Q%1.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.36%
EBIT growth 3Y-24.35%
EBIT growth 5Y-5.63%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.89%
FCF growth 3Y-41.21%
FCF growth 5Y-10.28%
OCF growth 1Y-35.87%
OCF growth 3Y-36.92%
OCF growth 5Y-13.88%